Estrogen-induced hepatic toxicity and hepatic cancer: Differences between two closely related hamster species

Liver

Volumn 18, Issue 5, 1998, Pages 343-351

  Coe, J E ^a   Ishak, K G ^b   Ross, M J ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

Author keywords

Estrogen induced hepatic toxicity; Tumors

Indexed keywords

BILIRUBIN; ESTROGEN; ESTROGEN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BILIRUBIN BLOOD LEVEL; ELECTRON MICROSCOPY; FATTY LIVER; FEMALE; HAMSTER; INTRAHEPATIC BILE DUCT; JAUNDICE; LIPODYSTROPHY; LIVER CANCER; LIVER SINUSOID; LIVER TOXICITY; MALE; MICROSCOPY; NONHUMAN; STRAIN DIFFERENCE;

EID: 0031726768     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0676.1998.tb00816.x     Document Type: Article

References (31)

1. COE J E, ISHAK K G, Ross M J. Diethylstilbestrol-induced jaundice in the Chinese and Armenian hamster. Hepatology 1983; 3: 489-96.
2. COE J E, ISHAK K G, ROSS M J. Estrogen induction of hepatocellular carcinomas in Armenian hamsters. Hepatology 1990; 11: 570-7.
3. COE J E, ISHAK K G, WARD J M, ROSS M J. Tamoxifen prevents induction of hepatic neoplasia by zeranol, an estrogenic food contaminant. Proc Natl Acad Sci USA 1992; 89: 1085-9.
4. COE J E, Ross M J. Tamoxifen inhibits estrogen-induced hepatic injury in hamsters. Endocrinology 1988; 122: 137-44.
5. DALEN E, WESTERHOLM B. Occurrence of hepatic impairment in women jaundiced by oral contraceptives and in their mothers and sisters. Acta Med Scand 1974; 195: 459-63.
6. SHERLOCK S. Biliary secretory failure in man: the problem of cholestasis. Ann Intern Med 1966; 65: 397-408.
7. POPPER H. Cholestasis. Annu Rev Med 1968; 19: 39-56.
8. FORMAN D, VINCENT T J, DOLL R. Cancer of the liver and the use of oral contraceptives. Br Med J 1986; 292: 1357-61.
9. HENDERSON B S, PRESTON-MARTIN S, EDMONDSON H A, PETERS R L, PIKE M C. Hepatocellular carcinoma and oral contraceptives. Br J Cancer 1983; 48: 437-40.
10. COE J E. Hormonal influences on liver carcinogenesis. In: Huff J, Boyd J, Barrett J C eds. Cellular and molecular mechanisms of hormonal carcinogenesis. New York: Wiley-Liss, 1994: 391-411.
11. COE J E, ROSS M J. Medroxyprogesterone acetate induces diabetes insipidus in Chinese hamsters. Endocrinology 1986; 118: 2146-8.
12. RIEDEL M, RAFFLENBEUL W, LICHTLEN P. Ovarian sex steroids and atherosclerosis. Clin Investig 1993; 71: 406-12.
13. HSUEH A J, PECK E J, CLARK J H. Control of uterine estrogen receptor levels by progesterone. Endocrinology 1976; 98: 438-44.
14. MACDONALD R G, OKULICZ W D, LEAVITT W W. Progestrone induced inactivation of nuclear estrogen receptor in the hamster uterus is mediated by acid phosphatase. Biochem Biophys Res Commun 1982; 104: 570-6.
15. HORWITZ K B, MCGUIRE W L. Estrogen control of progesterone receptor in human breast cancer. J Biol Chem 1978; 253: 2223-8.
16. BENHAMOU B, GARCIA T, LEROUGE T, et al. A single amino acid that determines the sensitivity of progesterone receptors to RU486. Science 1992; 255: 206-9.
17. GRAY G O, LEAVITT W W. RU486 is not an antiprogestin in the hamster. J Steroid Biochem 1987; 28: 493-7.
18. YERGANIAN G. History and cytogenetics of hamsters. Prog Exp Tumor Res 1972; 16: 2-41.
19. ADLER S. Origin of the golden hamster Cricetus auratus as a laboratory animal. Nature 1948; 162: 256-7.
20. BENJAMIN S A, BROOKS A L. Spontaneous lesions in Chinese hamsters. Vet Pathol 1977; 14: 449-62.
21. ARIAS I M. Effects of a plant acid (icterogenin) and certain anabolic steroids on the hepatic metabolism of bilirubin and sulfobromophthalein (BSP). Ann N Y Acad Sci 1963; 104: 1014-25.
22. LENNON H D. Effect of several anabolic steroids on sulfobromophthalein (BSP) retention in rabbits. Steroids 1965; 5: 361-73.
23. GALLAGHER JR T F, MUELLER M N, KAPPAS A. Estrogen pharmacology. IV. Studies on the structural basis for estrogen-induced impairment of liver function. Medicine 1966; 45: 471-82.
24. ROBINS S J, FASULO J M, PATTON G M, SCHAEFER E J, SMITH D E, ORDOVAS J M. Gender differences in the development of hyperlipemia and atherosclerosis in hybrid hamsters. Metabolism 1995; 44: 1326-31.
25. Rossouw J E. Estrogens for prevention of coronary heart disease. Circulation 1996; 94: 2982-3985.
26. WINKLER K, POULSEN H. Liver disease with periportal sinusoidal dilatation. A possible complication to contraceptive steroids. Scand J Gastroenterol 1975; 10: 699-704.
27. HERESBACH D, DEUGNIER Y, BRISSOT P, BOUREL M. Dilatations sinusoidales et prise de contraceptifs oraux A propos d'un cas avec revue de la litterature. Ann Gastroenterol Hepatol 1988; 24: 189-91.
28. WINKLER K, CHRISTOFFERSEN P. A reappraisal of Poulsen's disease, (hepatic zone 1 sinusoidal dilatation). APMIS Suppl 1991; 23: 86-90.
29. FISHER M R, NEIMAN H L. Periportal sinusoidal dilatation associated with pregnancy. Cardiovasc Intervent Radiol 1984; 7: 299-302.
30. RAUFMAN J P, MILLER D L, GUMUCIO J J. Estrogen-induced zonal changes in rat liver sinusoids. Gastroenterology 1980; 79: 1174-7.
31. BALAZS M. Sinusoidal dilatation of the liver in patients on oral contraceptives. Electron microscopial study of 14 cases. Exp Pathol 1988; 35: 231-7.